{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:03:05Z","timestamp":1792098185560,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T00:00:00Z","timestamp":1369785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s10384-013-0250-z","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T01:30:13Z","timestamp":1369704613000},"page":"402-409","source":"Crossref","is-referenced-by-count":2,"title":["Effects of l-arginine on anatomical and electrophysiological deterioration of the eye in a rodent model of nonarteritic ischemic optic neuropathy"],"prefix":"10.1007","volume":"57","author":[{"given":"Hideki","family":"Chuman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Maekubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Osako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michitaka","family":"Ishiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Nao-i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,29]]},"reference":[{"key":"250_CR1","first-page":"349","volume-title":"Walsh & Hoyt\u2019s Clinical Neuro-Ophthalmology","author":"AC Arnold","year":"2005","unstructured":"Arnold AC. Ischemic optic neuropathy. In: Miller NR, Newman NJ, editors. Walsh & Hoyt\u2019s Clinical Neuro-Ophthalmology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 349\u201384.","edition":"6"},{"key":"250_CR2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9394(14)70999-7","volume":"123","author":"MG Hattenhauer","year":"1997","unstructured":"Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic ischemic optic neuropathy. Am J Ophthalmol. 1997;123:103\u20137.","journal-title":"Am J Ophthalmol"},{"key":"250_CR3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.1995.03520320035038","volume":"273","author":"The Ischemic Optic Neuropathy Decompression Trial Research Group","year":"1995","unstructured":"The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273:625\u201332.","journal-title":"JAMA"},{"key":"250_CR4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0161-6420(87)33350-0","volume":"84","author":"M Beri","year":"1987","unstructured":"Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology. 1987;84:1020\u20138.","journal-title":"Ophthalmology"},{"key":"250_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","volume":"55","author":"EJ Atkins","year":"2010","unstructured":"Atkins EJ, Bruce BB, Newman NJ, Biousse V. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2010;55:47\u201363.","journal-title":"Surv Ophthalmol"},{"key":"250_CR6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00417-008-0805-8","volume":"246","author":"SS Hayreh","year":"2008","unstructured":"Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1029\u201346.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"250_CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0002-9394(14)72114-2","volume":"122","author":"AC Arnold","year":"1996","unstructured":"Arnold AC, Hepler RS, Lieber M, Alexander JM. Hyperbaric oxygen therapy for nonarteritic ischemic optic neuropathy. Am J Ophthalmol. 1996;122:535\u201341.","journal-title":"Am J Ophthalmol"},{"key":"250_CR8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10384-005-0304-y","volume":"50","author":"T Fujikado","year":"2006","unstructured":"Fujikado T, Morimoto T, Matsushita K, Shimojo H, Okawa Y, Tano Y. Effect of transcorneal electric stimulation in patients with non-arteritic ischemic optic neuropathy or traumatic optic neuropathy. Jpn J Ophthalmol. 2006;50:266\u201373.","journal-title":"Jpn J Ophthalmol"},{"key":"250_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/WNO.0b013e31814b273d","volume":"27","author":"JL Bennett","year":"2007","unstructured":"Bennett JL, Thomas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol. 2007;27:238\u201340.","journal-title":"J Neuroophthalmol"},{"key":"250_CR10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/WNO.0b013e31814a5a9a","volume":"27","author":"B Kaderli","year":"2007","unstructured":"Kaderli B, Avci R, Yucel A, Guler K, Gellisken O. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic ischemic optic neuropathy. J Neuroophthalmol. 2007;27:164\u20138.","journal-title":"J Neuroophthalmol"},{"key":"250_CR11","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/archopht.1989.01070020825022","volume":"177","author":"RC Sergott","year":"1989","unstructured":"Sergott RC, Cohen MS, Bosley TM, Savino PJ. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol. 1989;177:1743\u201354.","journal-title":"Arch Ophthalmol"},{"key":"250_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/WNO.0b013e31814a61ae","volume":"3","author":"SE Kelman","year":"2007","unstructured":"Kelman SE. Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study? J Neuroophthalmol. 2007;3:161\u20133.","journal-title":"J Neuroophthalmol"},{"key":"250_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.preteyeres.2011.02.003","volume":"30","author":"SL Bernstein","year":"2011","unstructured":"Bernstein SL, Johnson MA, Miller NR. Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog Retin Eye Res. 2011;30:167\u201387.","journal-title":"Prog Retin Eye Res"},{"key":"250_CR14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s10384-012-0167-y","volume":"56","author":"H Chuman","year":"2012","unstructured":"Chuman H, Maekubo T, Oosako T, Kodama Y, Ishiai M, Nao-I N. Rodent model of nonarteritic ischemic optic neuropathy and its electrophysiological evaluation. Jpn J Ophthalmol. 2012;56:518\u201327.","journal-title":"Jpn J Ophthalmol"},{"key":"250_CR15","doi-asserted-by":"crossref","unstructured":"Maekubo T, Chuman H, Kodama Y, Nao-I N. Evaluation of the retinal nerve fiber thickness around the optic disc using optical coherence tomography of rodent model of nonarteritic ischemic optic neuropathy. Jpn J Ophthalmol. 2013;57:327\u201332.","DOI":"10.1007\/s10384-012-0195-7"},{"key":"250_CR16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0140-6736(90)92196-O","volume":"336","author":"T Nakai","year":"1990","unstructured":"Nakai T, Hishikawa K, Suzuki H, Saruta T, Kato R. l-Arginine-induced hypotension. Lancet. 1990;336:696.","journal-title":"Lancet"},{"key":"250_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jjp.66.167","volume":"66","author":"T Nakaki","year":"1994","unstructured":"Nakaki T, Kato R. Beneficial circulatory effect of l-arginine. Jpn J Pharmacol. 1994;66:167\u201371.","journal-title":"Jpn J Pharmacol"},{"key":"250_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jop.1995.11.1","volume":"11","author":"GYC Chiou","year":"1995","unstructured":"Chiou GYC, Liu SXL, Li BHP, Chiang CH, Varma RS. Ocular hypotensive effect of l-arginine and its derivatives and their actions on ocular blood flow. J Ocul Pharmacol Ther. 1995;11:1\u201310.","journal-title":"J Ocul Pharmacol Ther"},{"key":"250_CR19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1248\/bpb.19.1149","volume":"19","author":"K Urabe","year":"1996","unstructured":"Urabe K, Matsumura Y, Nonaka H, Nishiura M, Maeda K, Morimoto S. Role of endogenous angiotensin II in renal hemodynamic and excretory responses to l-arginine infusion. Biol Pharm Bull. 1996;19:1149\u201353.","journal-title":"Biol Pharm Bull"},{"key":"250_CR20","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.ATV.14.10.1529","volume":"14","author":"PS Tsao","year":"1994","unstructured":"Tsao PS, Teilmeier G, Singer AH, Leung LL, Cooke JP. l-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:1529\u201333.","journal-title":"Arterioscler Thromb"},{"key":"250_CR21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0049-3848(97)00233-8","volume":"88","author":"M Marietta","year":"1997","unstructured":"Marietta M, Facchinetti F, Neri I, Volpe A, Torelli G. l-Arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release. Thromb Res. 1997;88:229\u201335.","journal-title":"Thromb Res"},{"key":"250_CR22","first-page":"379","volume":"96","author":"JP Cooke","year":"1997","unstructured":"Cooke JP, Dzau VJ. Derangements of the nitric oxide synthase pathway, l-arginine, and cardiovascular diseases. Circulation. 1997;96:379\u201382.","journal-title":"Circulation"},{"key":"250_CR23","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/jcbfm.2010.149","volume":"30","author":"GWJ Harston","year":"2010","unstructured":"Harston GWJ, Sutherland BA, Kennedy J, Buchan AM. The contribution of l-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab. 2010;30:1804\u201316.","journal-title":"J Cereb Blood Flow Metab"},{"key":"250_CR24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.58.5.827","volume":"58","author":"Y Koga","year":"2002","unstructured":"Koga Y, Ishibashi M, Ueki I, Yatsuga S, Fukiyama R, Akita Y, et al. Effects of l-arginine on acute phase of strokes in three patients with MELAS. Neurology. 2002;58:827\u20138.","journal-title":"Neurology"},{"key":"250_CR25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","volume":"64","author":"Y Koga","year":"2005","unstructured":"Koga Y, Akita Y, Nishioka J, Yatsuga S, Povalko N, Tanabe Y, et al. l-Arginine improves the symptoms of stroke-like episodes in MELAS. Neurology. 2005;64:710\u20132.","journal-title":"Neurology"},{"key":"250_CR26","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1167\/iovs.03-0274","volume":"44","author":"SL Bernstein","year":"2003","unstructured":"Bernstein SL, Guo Y, Kelman SE, Flower RW, Johnson MA. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2003;44:4153\u201362.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"250_CR27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0042-6989(81)90016-X","volume":"21","author":"MC Campbell","year":"1981","unstructured":"Campbell MC, Hughes A. An analytic, gradient index schematic lens and eye for the rat which predicts aberrations for finite pupils. Vis Res. 1981;21:1129\u201348.","journal-title":"Vis Res"},{"key":"250_CR28","first-page":"6503","volume":"51","author":"L Guo","year":"2010","unstructured":"Guo L, Normando M, Nizari S, Lara D, Cordeiro M. Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and Spectral domain OCT. Invest Ophthalmol Vis Sci. 2010;51:6503\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"250_CR29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.64.4.247","volume":"64","author":"D McLeod","year":"1980","unstructured":"McLeod D, Marshall J, Kohner EM. Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol. 1980;64:247\u201361.","journal-title":"Br J Ophthalmol"},{"key":"250_CR30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jneumeth.2010.07.037","volume":"192","author":"P Grieshaber","year":"2010","unstructured":"Grieshaber P, Lageze WA, Noack C, Boehringer D, Biermann J. Staining of fluorogold-prelabeled retinal ganglion cells with calcein-AM: a new method for assessing cell vitality. J Neurosci Methods. 2010;192:233\u20139.","journal-title":"J Neurosci Methods"},{"key":"250_CR31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10384-009-0657-8","volume":"53","author":"Y Tagami","year":"2009","unstructured":"Tagami Y, Kurimoto T, Miyoshi T, Morimoto T, Sawai H, Mimura O. Axonal regeneration induced by repetitive electrical stimulation of crushed optic nerve in adult rats. Jpn J Ophthalmol. 2009;53:257\u201366.","journal-title":"Jpn J Ophthalmol"},{"key":"250_CR32","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1167\/iovs.07-1050","volume":"49","author":"T Jehle","year":"2008","unstructured":"Jehle T, Wingert K, Dimitriu C, Meschede W, Lasseck J, Bach M, et al. Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology. Invest Ophthalmol Vis Sci. 2008;49:1056\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"250_CR33","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archopht.1977.04450090075006","volume":"95","author":"SS Hayreh","year":"1977","unstructured":"Hayreh SS. Optic disc edema in raised intracranial pressure V. Pathogenesis. Arch Ophthalmol. 1977;95:1553\u201365.","journal-title":"Arch Ophthalmol"},{"key":"250_CR34","first-page":"256","volume":"21","author":"SS Hayreh","year":"1981","unstructured":"Hayreh SS, Massanari RM, Yamada T, Hayreh SM. Experimental allergic encephalomyelitis I. Optic nerve and central nervous system manifestations. Invest Ophthalmol Vis Sci. 1981;21:256\u201369.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"250_CR35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.cdd.4400580","volume":"6","author":"SA Lipton","year":"1999","unstructured":"Lipton SA. Neuronal protection and destruction by NO. Cell Death Differ. 1999;6:943\u201351.","journal-title":"Cell Death Differ"},{"key":"250_CR36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.pharmtox.41.1.79","volume":"41","author":"RH B\u00f6ger","year":"2001","unstructured":"B\u00f6ger RH, Bode-B\u00f6ger SM. The clinical pharmacology of l-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79\u201399.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"250_CR37","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0140-6736(91)92372-9","volume":"338","author":"H Drexler","year":"1991","unstructured":"Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by l-arginine. Lancet. 1991;338:1546\u201350.","journal-title":"Lancet"},{"key":"250_CR38","first-page":"421","volume":"62","author":"B Bednarz","year":"2005","unstructured":"Bednarz B, Jaxa-Chamiec T, Maciejewski P, Szpajer M, Janik K, Gniot J, et al. Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. Kardiol Pol. 2005;62:421\u20137.","journal-title":"Kardiol Pol."},{"key":"250_CR39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.295.1.58","volume":"295","author":"SP Schulman","year":"2006","unstructured":"Schulman SP, Becker LC, Kass DA, Champion SC, Terrin ML, Forman S, et al. l-Arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295:58\u201364.","journal-title":"JAMA"},{"key":"250_CR40","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.wnl.0000220197.36849.1e","volume":"66","author":"Y Koga","year":"2006","unstructured":"Koga Y, Akita Y, Junko N, Yatsuga S, Povalko N, Fukiyama R, et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology. 2006;66:1766\u20139.","journal-title":"Neurology"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-013-0250-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-013-0250-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-013-0250-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:20:38Z","timestamp":1559146838000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-013-0250-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,29]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1007\/s10384-013-0250-z","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,29]]}}}